大行评级|小摩:上调诺和诺德目标价至275丹麦克朗,维持“中性”评级

格隆汇
Aug 25
摩根大通发布研究报告,将诺和诺德2027年12月目标价从250丹麦克朗上调至275丹麦克朗,维持“中性”评级。摩根大通将2026年销售预测上调5%,主要得益于Ozempic预测的上修;此外,Wegovy在美国以外市场的增长优于预期,亦推动相关预测走高。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10